Member Info for Sangijuelas1

Finch listed the other day via Nasdaq IPO. They are quite well regarded and are mentioned in this Forbes article.
https://www.forbes.com/sites/susanadams/2020/02/07/drugs-from-bugs-why-gates-zuck-and-benioff-think-the-next-blockbusters-will-come-from-inside-your-gut/?sh=1cfd789c57de

Some similarities with Seres in that they use a consortia approach rather than the single strain favoured by 4D. Also one of their lead candidates is for recurrent C Difficil although they are also looking beyond gut disease with autism included in their pipeline.

They opened at $17, went up to $22 and are now down at $19. They raised $128m from the IPO following on from a $90m raise they did in September.

They might have stolen some of our thunder

Phil just to be clear the £2.5bn would be if the offer came in the next 12 months while they are still doing trials and with lots of work still to be done to get to market.
If it was further down the line then I would significantly raise the valuation. I did say I would be disappointed if it was sold at this price hence implying that I think it's worth a lot more.

Of course it doesn't. I am conscious that I could be typing something here and missing an RNS saying we are being taken over at 1000p
I try to state my views in a nuanced way. Others are here saying this will definitely be up 500% by the end of the month. This is what I object to. Especially when those doing it are part of a cityboy spread bet gang or a pump and dump outfit like RG

What I take issue with is people talking about this being a stock that will have a meteoric rise by the end of this month or next month.
If you want to encourage others to invest here then talk about pipeline realities and the need to be patient rather than magical thinking about the Nasdaq listing and what this will deliver in the next week or two

I am still waiting for Wigscoff to highlight a negative post that I have ever made about the company's prospects

I am not really thinking in terms of this year. I am working to a longer time frame. The best that could happen in the next 12 months would be the following
a) More readouts and movement around FDA fast track approval for the Keytruda combo. Not sure if this could take the form of actually getting to market. Axel Glasmacher seemed to think you needed to have data for over 100 patients on each indication e. g. RCC or NSCL cancers but one of the analysts, possibly Chardan, suggested can be achieved with less.
b) Truly ground breaking data on efficacy of MRx0518 as a monotherapy or more positive read outs coming from the PC trial.
c) Confirmation that vaccine candidates have actually been handed over to Merck for them to develop further
d) A licensing partnership for Blautix
e) Good initial data from the Asthma trial (covid 19 as a complete wild card here)
f) Another major partnership with say Bristol Myers Squibb for a drug like Opdivo

If all or some of these come to pass I would not be surprised by a sustainable SP of about 400p upwards.

Regarding TO potential I would be disappointed if we were sold for less than £2.5bn

I am trying to keep the BB honest and stop it from being dominated by spread betters who have never been here before a week or two ago and want to bid the price up a few pence so they can cash out by making absurd predictions about 500p by next Thursday

Go on Wigscoff. Show me one negative thing I have said in all my posts about the company's prospects.
Show me. Quote me what I have said that so offends you

I posted this last week. So don't listen to me. What do I know?

"My point is don't jump on here with the expectation that this will jump to 180 next week because of Nasdaq. You will be disappointed

I will stick my neck on the line and say now by next Friday or the one after we will not close over 145. Unless there's pipeline news. If I am wrong you can shoot me down then and I will be here to take it and accept that I am wrong.

If you are going to buy in do it for the pipeline. I am currently in 2 Nasdaq biotechs and they have not made me rich so far. Some of the trading on them has also been very thin. Mainly algo trades by the look of it.
"

Have you got any thing other than calling people abusive names?
How about a really tough question on 4D?

Yeah that's right Wigscoff. Ignore the ones that has been saying on multiple occasions in the last few months that a Nasdaq listing will not be not the catalyst for a meaningful share price rise

Stop trying to obfuscate and conflate 2 things Scrambler.
I don't disagree with the potential future valuations
I disagree with the time frame you are working to when you have been stating that it will be over 500p by the end of the week or month with no catalyst

So test me on what I know. I will get back with an answer within 3 minutes

Wigscoff below is what you posted on PREM. You are talking about valuations of upwards of 500p but you would need to stick around quite some time to see this and you won't be here because you are a trader. You want your 10 or 20 % and then you will be never seen again.

You just want to bid the price up to say 160 to take your profit.

These are your own words.

"I am a trader. That’s why I’m here. I don’t need to give you a list of reasons for my entry"

Except I have been here since 2017 and I know more about 4D than the rest of you put together. There are people here who had never even heard of Thetanix

Rule 1 of investing. You can always buy 4D cheaper.

If he hasn't already started wait, til Oliveira starts dumping now that he can buy LBPS.

Nice spot Rollininit

Rollininit it went up to a tenner cos Woodford bought them all with his massively oversized fund eventually having to sell them all for 33p

Just a reminder here of your comment made in August. Strange that your price target then was 50p but now it's 500p purely on the basis of Nasdaq listing.

"I'm a holder but expect a dip back below 60p as the news is good for the market overall but 4d have a different approach. This will rerate once 4d produces news of it's own. I'm a holder but not adding as this has risen to quickly today. I hope I'm wrong but I will add again at 50p if it gets there".